National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anidulafungin
A cyclic lipopeptide echinocandin derivative with antifungal activity. Anidulafungin inhibits 1,3 beta-D-glucan synthase, an enzyme involved in fungal cell wall synthesis, resulting in cell lysis and death. This agent is active against Candida species and Aspergillus. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:V-echinocandin
VER-002
US brand name:Eraxis
Code name:LY303366



Previous:Angiocept, angiogenesis inhibitor GT-111, angiostatin, Angiozyme, anguidine
Next:aniline mustard, annamycin liposomal, Ansaid, Antabuse, anthracycline analogue GPX-150

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov